A Comparison of Murine and Human Immunoproteomes of Helicobacter pylori Validates the Preclinical Murine Infection Model for Antigen Screening

ABSTRACT Preclinical mouse infection models are widely used for Helicobacter vaccine development, but how well such models mimic important aspects of human infections is unknown. A comparison of Helicobacter pylori immunoproteomes of infected mice with previously reported patient data reveals a high agreement in the antigens recognized, suggesting that H. pylori in vivo protein composition and recognition by the host immune system are comparable in mice and humans. Murine Helicobacter models may thus be valid to screen antigens for human vaccination.

[1]  T. Meyer,et al.  Identification of Surface Proteins of Helicobacter pylori by Selective Biotinylation, Affinity Purification, and Two-dimensional Gel Electrophoresis* , 2002, The Journal of Biological Chemistry.

[2]  T. Meyer,et al.  Proteome Analysis of Secreted Proteins of the Gastric Pathogen Helicobacter pylori , 2002, Infection and Immunity.

[3]  Johannes Söllner,et al.  Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  L. Huber,et al.  Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis , 2002, Proteomics.

[5]  Toni Aebischer,et al.  Immunoproteomics of Helicobacter pylori infection and relation to gastric disease , 2002, Proteomics.

[6]  M. Blaser,et al.  Heterogeneity of Helicobacter pylori cag genotypes in experimentally infected mice. , 2001, FEMS microbiology letters.

[7]  B. Guy,et al.  Assessment of Helicobacter pylori Gene Expression within Mouse and Human Gastric Mucosae by Real-Time Reverse Transcriptase PCR , 2001, Infection and Immunity.

[8]  L. Brady,et al.  IVIAT: a novel method to identify microbial genes expressed specifically during human infections. , 2000, Trends in microbiology.

[9]  T. Meyer,et al.  Comparative proteome analysis of Helicobacter pylori , 2000, Molecular microbiology.

[10]  W. Goebel,et al.  Identification of Immunodominant Antigens fromHelicobacter pylori and Evaluation of Their Reactivities with Sera from Patients with Different Gastroduodenal Pathologies , 2000, Infection and Immunity.

[11]  A. Lee,et al.  Animal models of gastroduodenal ulcer disease. , 2000, Bailliere's best practice & research. Clinical gastroenterology.

[12]  B. Grignon,et al.  Phenotypic changes of Helicobacter pylori components during an experimental infection in mice. , 1999, FEMS immunology and medical microbiology.

[13]  M. Blaser,et al.  Phenotypic diversity in Lewis expression of Helicobacter pylori isolates from the same host. , 1999, The Journal of laboratory and clinical medicine.

[14]  A. Blum,et al.  Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. , 1999, Gastroenterology.

[15]  S. Czinn,et al.  Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice. , 1999, Cellular immunology.

[16]  J. Pappo,et al.  Helicobacter pylori Infection in Immunized Mice Lacking Major Histocompatibility Complex Class I and Class II Functions , 1999, Infection and Immunity.

[17]  T. Monath,et al.  Immunization of Mice with Urease Vaccine Affords Protection against Helicobacter pylori Infection in the Absence of Antibodies and Is Mediated by MHC Class II–restricted Responses , 1998, The Journal of experimental medicine.

[18]  K. Fry,et al.  Identification of potential diagnostic and vaccine candidates of Helicobacter pylori by "proteome" technologies. , 1998, Helicobacter.

[19]  K. Fry,et al.  Identification of Potential Diagnostic and Vaccine Candidates ofHelicobacter pylori by Two-Dimensional Gel Electrophoresis, Sequence Analysis, and Serum Profiling , 1998, Clinical Diagnostic Laboratory Immunology.

[20]  A. Labigne,et al.  Immune Responses of Specific-Pathogen-Free Mice to Chronic Helicobacter pylori (Strain SS1) Infection , 1998, Infection and Immunity.

[21]  T. Meyer,et al.  Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B. , 1998, Vaccine.

[22]  M F Dixon,et al.  A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. , 1997, Gastroenterology.

[23]  M. Blaser,et al.  Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa , 1992, The Journal of experimental medicine.

[24]  J. Keenan,et al.  A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection. , 2000, FEMS microbiology letters.

[25]  A. Lee,et al.  Gastric mucosa-associated lymphoid tissue lymphoma: implications of animal models on pathogenic and therapeutic considerations--mouse models of gastric lymphoma. , 2000, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[26]  A. Lee,et al.  Isolation of recombinant protective Helicobacter pylori antigens. , 1999, Infection and immunity.